A Novel Target and Approach for Identifying Antivirals against Molluscum Contagiosum Virus
- 1 December 2014
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 58 (12) , 7383-7389
Abstract
The dermatological disease molluscum contagiosum (MC) presents as lesions restricted solely to the skin. The poxvirus molluscum contagiosum virus (MCV) is responsible for this skin disease that is easily transmitted through casual contact among all populations, with greater frequency in children and immunosuppressed individuals. In addition, sexual transmission of MCV in adolescents and adults is a health concern. Although the skin lesions ultimately resolve in immunocompetent individuals, they can persist for extended periods, be painful, and result in scarring. Treatment is problematic, and there is no drug that specifically targets MCV. The inability of MCV to propagate in cell culture has impeded drug development. To overcome these barriers, we integrated three new developments. First, we identified a new MCV drug target (mD4) that is essential for processive DNA synthesis in vitro . Second, we discovered a small chemical compound that binds to mD4 and prevents DNA synthesis in vitro . Third, and most significant, we engineered a hybrid vaccinia virus (mD4-VV) in which the natural vaccinia D4 (vD4) gene is replaced by the mD4 target gene. This hybrid virus is dependent on mD4 for viral growth in culture and is inhibited by the small compound. This target system provides, for the first time, a platform and approach for the discovery and evaluation of new therapeutics that can be used to treat MC.Keywords
This publication has 28 references indexed in Scilit:
- Evaluation of the Role of the Vaccinia Virus Uracil DNA Glycosylase and A20 Proteins as Intrinsic Components of the DNA Polymerase HoloenzymeJournal of Biological Chemistry, 2011
- Identification of Inhibitors that Block Vaccinia Virus Infection by Targeting the DNA Synthesis Processivity Factor D4Journal of Medicinal Chemistry, 2011
- Vaccinia Virus D4 Mutants Defective in Processive DNA Synthesis Retain Binding to A20 and DNAJournal of Virology, 2010
- Identification of polymerase and processivity inhibitors of vaccinia DNA synthesis using a stepwise screening approachAntiviral Research, 2008
- Identification of Non-Nucleoside DNA Synthesis Inhibitors of Vaccinia Virus by High-Throughput ScreeningJournal of Medicinal Chemistry, 2008
- Crystal structure of vaccinia virus uracil-DNA glycosylase reveals dimeric assemblyBMC Structural Biology, 2007
- Epidemiology and Impact of Childhood Molluscum Contagiosum: A Case Series and Critical Review of the LiteraturePediatric Dermatology, 2005
- Vaccinia Virus Uracil DNA Glycosylase Has an Essential Role in DNA Synthesis That Is Independent of Its Glycosylase Activity: Catalytic Site Mutations Reduce Virulence but Not Virus Replication in Cultured CellsJournal of Virology, 2003
- Characterization of Recombinant Vaccinia Viruses and Their ProductsCurrent Protocols in Molecular Biology, 1998
- MOLLUSCUM CONTAGIOSUMInternational Journal of Dermatology, 1994